Pelthos Total Current Assets from 2010 to 2025
| PTHS Stock | 25.71 0.79 2.98% |
Total Current Assets | First Reported 2010-12-31 | Previous Quarter 1.4 M | Current Value 1.4 M | Quarterly Volatility 476.6 K |
Check Pelthos Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pelthos Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 825.7 K, Total Revenue of 0.0 or Gross Profit of 159.9 K, as well as many indicators such as Price To Sales Ratio of 27.23, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Pelthos financial statements analysis is a perfect complement when working with Pelthos Therapeutics Valuation or Volatility modules.
Pelthos | Total Current Assets | Build AI portfolio with Pelthos Stock |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Pelthos Stock Analysis
When running Pelthos Therapeutics' price analysis, check to measure Pelthos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pelthos Therapeutics is operating at the current time. Most of Pelthos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pelthos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pelthos Therapeutics' price. Additionally, you may evaluate how the addition of Pelthos Therapeutics to your portfolios can decrease your overall portfolio volatility.